Hepatotoxicity from Rifampin Plus Pyrazinamide
- 1 October 2001
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 164 (7), 1112-1113
- https://doi.org/10.1164/ajrccm.164.7.2109052
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Adherence to Isoniazid Prophylaxis in the HomelessArchives of Internal Medicine, 2000
- Hepatotoxicity Associated With Isoniazid Preventive TherapyJAMA, 1999
- A Tuberculin Screening and Isoniazid Preventive Therapy Program in an Inner-City PopulationAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Twice weekly tuberculosis preventive therapy in HIV infection in ZambiaAIDS, 1998
- Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infectionThe Lancet, 1998
- A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1997
- Isoniazid-associated Hepatitis Deaths: A Review of Available InformationAmerican Review of Respiratory Disease, 1992
- USPHS Tuberculosis Short-Course Chemotherapy Trial 21: Effectiveness, Toxicity, and AcceptabilityAnnals of Internal Medicine, 1990
- Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical studyTubercle, 1980
- Isoniazid-Associated HepatitisAmerican Review of Respiratory Disease, 1972